← Back to Patent Explorer
US3873588A Expired / Lapsed US ⏱️ 0.0 years remaining

Orally administrable pharmaceutical iron preparation

Assignee: Aska Pharmaceutical Co Ltd
•
Filing: 1972-10-16
•
Granted: 1975-03-25
•
Expires: 1992-10-16
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract An orally administrable pharmaceutical iron preparation having gradual release activity which comprises an iron salt of a carboxyl group-containing water-soluble linear polymer. The carboxyl group-containing water-soluble linear polymer which forms the anion component of the foregoing iron salt, is selected from the group consisting of 1. A POLYMER OF AT LEAST ONE UNSATURATED MONOMER SELECTED FROM THE GROUP CONSISTING OF ACRYLIC ACID AND METHACRYLIC ACID, 2. A COPOLYMER OF MALEIC ACID WITH AT LEAST ONE VINYL COMPOUND SELECTED FROM THE GROUP CONSISTING OF VINYL ACETATE, A LOWER ALKYL VINYL ETHER, ACRYLIC ACID, A LOWER ALKYL ESTER OF ACRYLIC ACID, METHACRYLIC ACID, A LOWER ALKYL ESTER OF METHACRYLIC ACID AND VINYL ALCOHOL, AND 3. A COPOLYMER OF VINYL ALCOHOL WITH AN UNSATURATED MONOMER SELECTED FROM THE GROUP CONSISTING OF ACRYLIC ACID AND METHACRYLIC ACID.

Inventors

  • 👤 Yoshio Osawa
  • 👤 Koichiro Ueno
  • 👤 Koichi Dobashi
  • 👤 Hideichi Asano

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 13:51
CPC Classifications
C; C08; C08F; C08F8/00; C08F8/44; A; A61; A61K; A61K31/00; A61K31/28; A61K31/295; A61K33/00; A61K33/24; A61K33/26

Claims Analysis

Total Claims: 8
Claim 1
Independent Claim 170 words
AN ORALLY ADMINISTRABLE PHARMACEUTICAL IRON PREPARATION HAVING A GRADUALLY IRON-RELEASING ACIVITY WHICH CONSISTING ESSENTIALLY OF AN IRON SALT OF A WATER-SOLUBLE LINEAR POLYMER CONTAINING FROM 2 TO 16 MILLIMOLES OF CARBOXYLIC GROUPS PER GRAM OF THE POLYMER, SAID SALT CONTAINING BOUND IRON IN AN AMOUNT OF FROM ABOUT 2.5 TO ABOUT 33% BY WEIGHT BASED ON THE WEIGHT OF THE SALT, SAID POLYMER BEING SELECTED FROM THE GROUP CONSISTING OF (1) A POLYMER OF AT LEAST ONE UNSATURATED MONOMER SELECTED FROM THE GROUP CONSISTING OF ACRYLIC ACID AND METHACRYLIC ACID, (2) A COPOLYMER OF MALEIC ACID WITH AT LEAST ONE VINYL COMPOUND SELECTED FROM THE GROUP CONSISTING OF VINYL ACETATE, A LOWER ALKYL VINYL ETHER, ACRYLIC ACID A LOWER ALKYL ESTER OF ACRYLIC ACID, METHACRYLIC ACID, A LOWER ALKYL ESTER OF METHACRYLIC ACID AND VINYL ALCOHOL, AND (3) A COPOLYMER OF VINYL ALCOHOL WITH AN UNSATURATED MONOMER SELECTED FROM THE GROUP CONSISTING OF ACRYLIC ACID AND METHACRYLIC ACID, AND AT LEAST 50% BY WEIGHT OF SAID BOUND IRON BEING BIVALENT.
Claim 2
Dependent Claim 170 words
AN ORALLY ADMINISTRABLE PHARMACEUTICAL IRON PREPARATION HAVING A GRADUALLY IRON-RELEASING ACIVITY WHICH CONSISTING ESSENTIALLY OF AN IRON SALT OF A WATER-SOLUBLE LINEAR POLYMER CONTAINING FROM 2 TO 16 MILLIMOLES OF CARBOXYLIC GROUPS PER GRAM OF THE POLYMER, SAID SALT CONTAINING BOUND IRON IN AN AMOUNT OF FROM ABOUT 2.5 TO ABOUT 33% BY WEIGHT BASED ON THE WEIGHT OF THE SALT, SAID POLYMER BEING SELECTED FROM THE GROUP CONSISTING OF (1) A POLYMER OF AT LEAST ONE UNSATURATED MONOMER SELECTED FROM THE GROUP CONSISTING OF ACRYLIC ACID AND METHACRYLIC ACID, (2) A COPOLYMER OF MALEIC ACID WITH AT LEAST ONE VINYL COMPOUND SELECTED FROM THE GROUP CONSISTING OF VINYL ACETATE, A LOWER ALKYL VINYL ETHER, ACRYLIC ACID A LOWER ALKYL ESTER OF ACRYLIC ACID, METHACRYLIC ACID, A LOWER ALKYL ESTER OF METHACRYLIC ACID AND VINYL ALCOHOL, AND (3) A COPOLYMER OF VINYL ALCOHOL WITH AN UNSATURATED MONOMER SELECTED FROM THE GROUP CONSISTING OF ACRYLIC ACID AND METHACRYLIC ACID, AND AT LEAST 50% BY WEIGHT OF SAID BOUND IRON BEING BIVALENT.
Claim 3
Dependent Claim 34 words
The pharmaceutical iron preparation of claim 1 wherein said water-soluble linear polymer is a copolymer composed of 40 to 90 mole % of acrylic acid and 60 to 10 mole % of methacrylic acid.
Claim 4
Dependent Claim 69 words
The pharmaceutical iron preparation of claim 1 wherein said water-soluble linear polymer is a copolymer composed of 10 to 50 mole % of maleic acid and 90 to 50 mol % of a vinyl compound selected from the group consisting of vinyl acetate, a lower alkyl vinyl ether, acrylic acid, a lower alkyl ester of acrylic acid, methacrylic acid, a lower alkyl ester of methacrylic acid and vinyl alcohol.
Claim 5
Dependent Claim 37 words
The pharmaceutical iron preparation of claim 1 wherein said water-soluble linear polymer is a copolymer composed of 10 to 50 mole % of vinyl alcohol and 90 to 50 mole % of acrylic acid or methacrylic acid.
Claim 6
Independent Claim 245 words
A method of preparing an orally administrable iron salt having a sustained iron-releasing activity and being free of a resin Insoluble in gastric juice or intestinal fluid, which comprises mixing in an aqueous medium a water-soluble inorganic iron salt with a water-soluble linear polymer containing 2 to 16 millimoles of carboxylic groups, said polymer being selected from the group consisting of (1) a polymer of at least one unsaturated monomer selected from the group consisting of acrylic acid and methacrylic acid, (2) a copolymer of maleic acid with at least one vinyl compound selected from the group consisting of vinyl acetate, a lower alkyl vinyl ether, acrylic acid, a lower alkyl ester of acrylic acid, methacrylic acid, a lower alkyl ester of methacrylic acid and vinyl alcohol, and (3) a copolymer of vinyl alcohol with an unsaturated monomer selected from the group consisting of acrylic acid and methacrylic acid, and thereafter separating the resulting iron salt of said linear polymer as a solid by a procedure selected from: a. maintaining the pH of the resulting mixture at 5.0-8.0, b. evaporating to dryness the resulting mixture after removing foreign anions by means of an anion exchange resin, c. adding a water-miscible organic solvent to the resulting mixture after removing foreign anions by means of an anion exchange resin,, d. salting out the resulting mixture after removing foreign anions by means of an anion exchange resin, e. or a combination of two or more of the above.
Claim 7
Independent Claim 245 words
A method of preparing an orally administrable iron salt having a sustained iron-releasing activity and being free of a resin Insoluble in gastric juice or intestinal fluid, which comprises mixing in an aqueous medium a water-soluble inorganic iron salt with a water-soluble linear polymer containing 2 to 16 millimoles of carboxylic groups, said polymer being selected from the group consisting of (1) a polymer of at least one unsaturated monomer selected from the group consisting of acrylic acid and methacrylic acid, (2) a copolymer of maleic acid with at least one vinyl compound selected from the group consisting of vinyl acetate, a lower alkyl vinyl ether, acrylic acid, a lower alkyl ester of acrylic acid, methacrylic acid, a lower alkyl ester of methacrylic acid and vinyl alcohol, and (3) a copolymer of vinyl alcohol with an unsaturated monomer selected from the group consisting of acrylic acid and methacrylic acid, and thereafter separating the resulting iron salt of said linear polymer as a solid by a procedure selected from: a. maintaining the pH of the resulting mixture at 5.0-8.0, b. evaporating to dryness the resulting mixture after removing foreign anions by means of an anion exchange resin, c. adding a water-miscible organic solvent to the resulting mixture after removing foreign anions by means of an anion exchange resin,, d. salting out the resulting mixture after removing foreign anions by means of an anion exchange resin, e. or a combination of two or more of the above.
Claim 8
Dependent Claim 24 words
A method according to claim 5 wherein said iron salt of the linear polymer is dried at a temperature of from 60* to 120*C.

References Cited (Backward Citations)

US3027303A Cited
US3632637A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-03-24 1978-09-23 1979-03-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-03-24 1982-09-23 1983-03-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-03-24 1986-09-23 1987-03-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag